Study of BMS-181174 Resistance in Bladder Cancer Cells
Author Information
Author(s): H Xia, RJ Bleicher, X Hu, SK Srivastava, V Gupta, HA Zaren, SV Singh
Primary Institution: Cancer Research Laboratory, Mercy Cancer Institute, Mercy Hospital of Pittsburgh
Hypothesis
What mechanisms contribute to cellular resistance to BMS-181174 in a human bladder cancer cell line?
Conclusion
The study suggests that reduced DNA interstrand cross-link formation may be responsible for the resistance of the J82/BMS cell line to BMS-181174.
Supporting Evidence
- The J82/BMS cell line required a 2.6-fold higher concentration of BMS-181174 to achieve the same level of cell death as the parental J82 cells.
- The J82/BMS cell line showed collateral sensitivity to 5-fluorouracil but was more resistant to several other drugs.
- Lower activities of NADPH cytochrome P450 reductase and DT-diaphorase were observed in the J82/BMS cell line compared to J82.
Takeaway
Researchers created a special bladder cancer cell line that doesn't respond well to a new drug, and they think this is because the drug doesn't damage the DNA as much in these cells.
Methodology
The study involved creating a resistant cell line by exposing parental cells to increasing concentrations of BMS-181174 over 17 months and assessing drug sensitivity through colony formation assays.
Limitations
The exact mechanism of reduced DNA interstrand cross-link formation in the resistant cell line remains unclear.
Statistical Information
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website